⌘K

Login Start Free

Home/Filings/4/0001415889-24-014769

4//SEC Filing

WELCH DANIEL G 4

Accession 0001415889-24-014769

CIK 0001811063other

View on SEC.gov Company Profile

Filed

May 28, 8:00 PM ET

Accepted

May 29, 4:38 PM ET

Size

10.6 KB

Accession

0001415889-24-014769

Insider Transaction Report

Form 4

Period: 2024-05-24

Nuvation Bio Inc.NUVB

Director

Transactions

Exercise/Conversion
Class A Common Stock
2024-05-24$1.74/sh+293,203$510,173→ 293,203 total
Exercise/Conversion
Stock Option (Right to Buy)
2024-05-24−366,744→ 0 total
Exercise: $1.64Exp: 2033-05-14→ Class A Common Stock (366,744 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2024-05-24−293,203→ 19,547 total
Exercise: $1.74Exp: 2030-07-21→ Class A Common Stock (293,203 underlying)
Exercise/Conversion
Class A Common Stock
2024-05-24$1.64/sh+366,744$601,460→ 659,947 total

Footnotes (2)

[F1]Option vests in 48 equal monthly installments from July 22, 2020.
[F2]Option is fully vested and exercisable.

Documents

1 file

4
form4-05292024_080529.xmlPrimary

Issuer

Nuvation Bio Inc.

CIK 0001811063

Entity typeother

Related Parties

1

filerCIK 0001206199

Filing Metadata

Form type: 4
Filed: May 28, 8:00 PM ET
Accepted: May 29, 4:38 PM ET
Size: 10.6 KB

View on SEC.gov